Wang JB, Huang CM, Zheng CH, Li P, Xie JW, Lin JX, Lu J. Role of 3DCT in laparoscopic total gastrectomy with spleen-preserving splenic lymph node dissection. World J Gastroenterol 2014; 20(16): 4797-4805 [PMID: 24782634 DOI: 10.3748/wjg.v20.i16.4797]
Corresponding Author of This Article
Chang-Ming Huang, Professor, Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350001, Fujian Province, China. hcmlr2002@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Apr 28, 2014; 20(16): 4797-4805 Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4797
Table 1 Patient characteristics in group computed tomography with 3D imaging and group NO-computed tomography with 3D imaging
Patient characteristics
Group NO-3DCT
Group 3DCT
P value
No. of patients
81
231
Age (yr)
59.48 ± 10.82
61.34 ± 10.38
0.542
Gender
0.484
Male
58
178
Female
23
52
BMI, kg/m2
21.67 ± 3.24
21.95 ± 2.74
0.273
Tumour size, mm
57.53 ± 23.66
55.76 ± 27.88
0.251
Histology
0.262
Differentiated
29
98
Undifferentiated
52
133
Depth of invasion
0.098
pT1a
5
10
pT1b
6
9
pT2
1
22
pT3
29
87
pT4a
40
103
Lymph node metastasis
0.090
pN0
25
45
pN1
13
37
pN2
12
43
pN3
31
106
TNM stage
0.487
Ia
6
15
Ib
4
12
IIa
15
25
IIb
9
27
IIIa
12
31
IIIB
12
52
IIIC
23
69
Table 2 Operative data in group computed tomography with 3D imaging and group NO-computed tomography with 3D imaging
Group NO-3DCT
Group 3DCT
P value
Operation time, min
189.56 ± 48.36
173.65 ± 27.12
0.007
Operation time at splenic hilum, min
24.47 ± 9.98
19.70 ± 5.59
0.001
Blood loss, mL
57.34 ± 30.78
50.18 ± 28.89
0.064
Blood loss at the splenic hilum, mL
17.92 ± 9.08
13.62 ± 4.50
0.001
No. of positive No. 10 lymph nodes
0.25 ± 0.79
0.24 ± 0.85
0.889
No. of retrieved No. 10 lymph nodes
2.48 ± 2.18
2.85 ± 2.33
0.225
No. of positive lymph nodes
7.97 ± 10.65
9.10 ± 10.08
0.414
No. of retrieved lymph nodes
39.47 ± 13.51
43.19 ± 15.64
0.067
Table 3 Postoperative data in group computed tomography with 3D imaging and group NO-computed tomography with 3D imaging
Group NO-3DCT
Group 3DCT
P value
Postoperative hospital stay, d
11.03 ± 2.84
12.29 ± 6.49
0.094
Day of first flatus, d
3.95 ± 1.07
4.19 ± 1.04
0.079
Day of first fluid diet, d
4.29 ± 1.12
4.55 ± 1.70
0.205
Day of first semifluid diet, d
7.85 ± 1.92
8.15 ± 3.52
0.463
Blood transfusion, n
0
0
1.000
Postoperative complications, n
11
35
0.731
Pulmonary infection, n
7
11
0.141
Abdominal infection, n
1
12
0.085
Chylous fistula, n
1
2
0.770
Wound problem, n
0
3
0.303
Anastomotic leakage, n
0
3
0.303
Anastomotic bleeding, n
1
3
0.965
Septicaemia, n
0
1
0.554
Postoperative mortality, n
0
0
1.000
Table 4 Subgroup comparison according to body mass index
BMI < 23 kg/m2 (n = 201)
BMI≥23 kg/m2 (n = 111)
Group NO-3DCT
Group 3DCT
P value
Group NO-3DCT
Group 3DCT
P value
No. of patients
56
145
25
86
Age, yr
57.73 ± 11.59
60.95 ± 11.43
0.745
63.40 ± 7.72
61.99 ± 8.37
0.807
Operation time, min
188.09 ± 52.63
171.38 ± 26.32
0.028
187.92 ± 32.00
177.44 ± 28.17
0.121
Operation time at splenic hilum, min
23.74 ± 9.56
19.39 ± 5.46
0.001
26.17 ± 11.01
20.27 ± 5.84
0.003
Blood loss, mL
61.27 ± 35.94
51.83 ± 22.66
0.073
48.33 ± 7.61
49.41 ± 34.73
0.670
Blood loss at splenic hilum, mL
17.98 ± 8.12
13.27 ± 4.96
0.000
17.78 ± 11.28
14.29 ± 3.39
0.054
No. of retrieved lymph nodes
38.38 ± 12.25
46.18 ± 16.86
0.002
42.09 ± 16.15
37.86 ± 11.48
0.172
No. of retrieved No. 10 lymph nodes
2.67 ± 2.27
3.20 ± 2.42
0.162
2.04 ± 1.94
2.23 ± 2.06
0.692
Postoperative hospital stay, d
10.69 ± 2.29
11.62 ± 5.84
0.256
11.79 ± 3.77
13.42 ± 7.36
0.299
Postoperative complications, n
9
18
0.495
2
17
0.169
Table 5 Subgroup comparison according to the number of cumulative laparoscopic spleen-preserving splenic hilar lymph node dissection cases
Less than 40 cases (n = 40)
More than 40 cases (n = 272)
Group NO-3DCT
Group 3DCT
P value
Group NO-3DCT
Group 3DCT
P value
No. of patients
18
22
59
213
Age, yr
61.05 ± 10.14
59.22 ± 13.46
0.827
63.81 ± 8.03
60.96 ± 10.52
0.053
Operation time, min
205.00 ± 67.36
199.44 ± 46.99
0.769
176.40 ± 27.83
173.39 ± 27.59
0.466
Operation time at the splenic hilum, min
30.27 ± 11.58
28.92 ± 11.61
0.779
23.85 ± 7.92
18.63 ± 4.40
0.000
Blood loss, mL
69.32 ± 37.49
66.35 ± 33.10
0.368
49.18 ± 23.25
50.29 ± 29.97
0.799
Blood loss at the splenic hilum, mL
30.27 ± 8.17
32.38 ± 13.61
0.514
15.10 ± 4.42
13.10 ± 4.17
0.005
No. of retrieved lymph nodes
34.97 ± 10.67
25.33 ± 10.26
0.140
43.54 ± 14.61
43.47 ± 15.56
0.980
No. of retrieved No. 10 lymph nodes
2.81 ± 2.00
2.33 ± 1.87
0.313
2.74 ± 2.33
2.88 ± 2.33
0.719
Postoperative hospital stay, d
12.87 ± 1.78
11.91 ± 2.59
0.112
11.93 ± 5.27
12.15 ± 6.37
0.809
Postoperative complications, n
3
3
0.789
8
32
0.779
Citation: Wang JB, Huang CM, Zheng CH, Li P, Xie JW, Lin JX, Lu J. Role of 3DCT in laparoscopic total gastrectomy with spleen-preserving splenic lymph node dissection. World J Gastroenterol 2014; 20(16): 4797-4805